Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05747365

Role of Endocrine Disruptors in Thyroid Cancer

Sponsor: Istituto Auxologico Italiano

View on ClinicalTrials.gov

Summary

the relationship between human exposure to EDCS and TC is poorly investigated and still unclear. The aim of this study is to evaluate the possible role of old and new generation endocrine disruptors in thyroid cancer. The primary aim is to evaluate the difference in the average levels of the main endocrine disruptors (PFAS, including: PFOA, PFOS, PFDA, PFUnA, PFHpS and possibly subsequently other categories, such as bisphenols, phthalates, parabens, PCBs, flame retardants) between patients with and without a diagnosis of thyroid cancer through highly sensitive, selective and precise mass spectrometry methods, such as liquid chromatography combined with tandem mass spectrometry (LC-MS / MS). The secondary aim is to evaluate the relationship between the concentrations of endocrine disruptors and some anamnestic variables studied (for example the type of diet, the use of personal care products).

Official title: Cross-sectional Case-control Study on the Role of Endocrine Disruptors in Thyroid Cancer

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

222

Start Date

2022-07-12

Completion Date

2025-07-31

Last Updated

2024-04-16

Healthy Volunteers

No

Interventions

DIAGNOSTIC_TEST

Blood and urine diagnostic evaluation

Blood and urine samples will be obtained from both case and control groups in order to evaluate EDCs concentrations

Locations (1)

Istituto Auxologico Italiano, IRCCS

Milan, Italy